Glucose Clamping made in Germany at ADA 2017

Meet the people behind Profil at booth #115

Christoph_Kapitza.pngSascha_Heckermann.pngLeszek_Nosek.pngTim_Heise.png

 

About the ADA Scientific Sessions and the ADA Forum

Like every year, Profil will be present at the ADA Scientific Sessions. We will have numerous posters again as well as some talks. Of course we look forward to this exciting event very much. 

We are proud that for the 2nd time, Profil will be a Supporting Sponsor of the ADA Forum, the yearly event hosted by TCOYD and The diaTribe Foundation in conjunction with the ADA Scientific Sessions. The event will be held at the Hard Rock Hotel, June 12th, 2017 starting at 6:30pm. Food and drinks will be served and as always there will be exciting high calibre scientific talks in a relaxed atmosphere. Learn more about the event here. 

Impaired-Glucose-Tolerance_Mitarbeiter.pngDr. Eric Zijlstra.pngThomas_Forst.pngLars_Bochmann.png

Visit the Profil booth and beat ClampArt®

We are proud to announce that this year Profil will have its very own booth at the conference (booth #115). Come visit us and chat about Glucose Clamping made in Germany. Let us surprise you with an opportunity to run your very own glucose clamp experiment right at the booth. The best clampers will have a chance to win an ADA textbook.

Here is a list of our scientific contributions at the ADA Scientific Sessions 

Oral Presentations

  • 380-OR - Efficacy and Safety of Oral Basal Insulin: Eight-Week Feasibility Study in People with Type 2 Diabetes

Poster Presentations

  • 964-P - Ultra-rapid BioChaperone Lispro (BCLIS) improves post-prandial blood glucose (PPG) excursions versus insulin lispro (LIS) in a 14-day treatment study in subjects with type 1 diabetes 
  • 994-P - Ultra-rapid BioChaperone Lispro (BCLIS) improves post-prandial blood glucose (PPG) control versus insulin lispro (LIS) in a 14-day treatment study in subjects with type 2 diabetes
  • 996-P - Proportional dose-exposure relationship of ultra-rapid BioChaperone Lispro (BCLIS) in healthy Japanese subjects
  • 1008-P - The Human Recombinant Biphasic Julphar Insulin 30/70 (JUL) is bioequivalent to Huminsulin Profil III (REF), an EU-Marketed Insulin
  • 1247-P - Sequential Treatment Escalation With Dapagliflozin And Saxagliptin Improves The Insulin And Glucagon Balance During A Hyperglycaemic Clamp
  • 1019-P - Comparative Pharmacokinetics (PK) and Pharmacodynamics (PD) of a Proposed Biosimilar Insulin Glargine and Lantus in People with Type 1 diabetes (T1D)
  • 978-P - A Novel Formulation of Insulin Lispro Containing Citrate and Treprostinil Shows Significantly Faster Absorption and an Improvement in Postprandial Glucose Excursions vs. Humalog in Patients with T2DM

Other things you should know about the ADA Scientific Sessions

  • You can meet with a Profil representative at the occasion of the ADA Scientific Sessions to discuss your research or product developments. Just send an email to lars.bochmann@profil.com or fill out the form on the right. We will be happy to welcome you at our booth #115

  • After the publication embargo is lifted, you can download some of our posters here. 

  • Are you at the Bio International Convention in San Diego just after the ADA? Then request a meeting with us and come to our booth (Booth 4507 - Germany Pavilion). You may fill out the form on the right to request a meeting or just use the Bio partnering tool.